中文名 | 坎利酮 |
英文名 | Canrenone |
别名 | 卡利酮 坎利酮 刊利酮 烯睾丙内酯 依普利酮杂质28 螺内酯EP杂质F 坎利酮溶液,100PPM 6-去氢睾(甾)酮-17α-丙酸-γ-内酯 雄甾-4,6-二烯-17β-醇-3-酮-17α-丙酸内酯 |
英文别名 | Luvion sc9376 SC 9376 RP 11641 Phanurane phanurane Canrenona Aldadiene CANRENONE Canrenone 11614 R.P Canrenonum NSC 261713 11614 R. P. BRN 0046602 CANRENONE-D4 UNII-78O20X9J0U Aldadiene (VAN) spirolactonesc14266 Spirolactone SC 14266 Canrenonum [INN-Latin] Canrenona [INN-Spanish] CANRENOIC ACID GAMMA LACTONE 5-17-11-00476 (Beilstein Handbook Reference) 4,6-ANDROSTADIEN[(17(B-1')-SPIRO-5')]-PERHYDROFURAN-2,3-DIONE 17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone 17-Hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone pregna-4,6-diene-21-carboxylicacid,17-hydroxy-3-oxo-,gamma-lactone,(17-alph Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (17alpha)- 17alpha-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone (8CI) 10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione (10R,13S,17R)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione (8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione |
CAS | 976-71-6 |
EINECS | 213-554-5 |
化学式 | C22H28O3 |
分子量 | 340.46 |
InChI | InChI=1/C22H28O3/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21)12-8-19(24)25-22/h3-4,13,16-18H,5-12H2,1-2H3/t16?,17?,18?,20-,21-,22+/m0/s1 |
密度 | 1.1236 (rough estimate) |
熔点 | 158-1600C |
沸点 | 416.25°C (rough estimate) |
比旋光度 | D +24.5° (chloroform) |
闪点 | 237.6°C |
水溶性 | 272.4ug/L(25 ºC) |
蒸汽压 | 8.95E-12mmHg at 25°C |
溶解度 | DMSO: 可溶20mg/mL,澄清 |
折射率 | 1.5000 (estimate) |
存储条件 | room temp |
外观 | 粉末 |
颜色 | white to beige |
物化性质 | 微黄色或乳白色结晶性粉末(乙酸乙酯)。熔点149-151℃,165℃固化并重熔。 |
体外研究 | Canrenone inhibits the production of eortieosterone, 18-hydroxydesoxyeortieosterone, 18-hydroxycorticosterone and aldosterone in a dose-dependent manner. Canrenone dose-dependently reduces platelet-derived growth factor–induced cell proliferation and motility. Canrenone inhibits the activity of the Na + /H + exchanger 1 induced by platelet-derived growth factor. |
体内研究 | Canrenone is the principal active metabolite of Spironolactone in the rat only for a limited period. During chronic treatment a difference developed between the effect of Spironolactone and Canrenone on the RAAS indicating a decrease in the anti-mineralocorticoid activity of Canrenone and an increase in the efficacy of Spironolactone. |
危险品标志 | Xn - 有害物品 N - 危害环境的物品 |
风险术语 | R40 - 少数报道有致癌后果。 R51/53 - 对水生生物有毒,可能对水体环境产生长期不良影响。 |
安全术语 | S36/37 - 穿戴适当的防护服和手套。 S61 - 避免释放至环境中。参考特别说明/安全数据说明书。 |
危险品运输编号 | UN 3077 9 / PGIII |
WGK Germany | 3 |
海关编号 | 29329990 |
上游原料 | 碘甲烷 丙酸钾 四氯苯醌 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!